Prof. Solange Peters | Oncology | Research Excellence Award

Lausanne University | Switzerland

Dr. Solange Peters is an internationally recognized medical oncologist and academic leader specializing in thoracic oncology. She serves as Director of the Oncology Department at Lausanne University Hospital and is a Full Professor at the University of Lausanne. Dr. Peters is widely known for her expertise in lung cancer, immunotherapy, and precision oncology, with a strong focus on clinical research and translational medicine. She has led and coordinated numerous international multicenter clinical trials and has contributed significantly to advancing treatment standards for thoracic malignancies. With extensive experience in medical education, she is actively involved in training oncology professionals worldwide. Dr. Peters has authored more than 500 peer-reviewed scientific publications and serves in key editorial roles for leading oncology journals. She has held prominent leadership positions in major international oncology organizations and is a strong advocate for multidisciplinary cancer care, innovation in clinical research, and the advancement of women in oncology.

Citation Metrics (Scopus)

70,000
50,000
10,000
  1000
        0

Citations
58,125

Documents
483
h-index
104

Citations

Documents

h-index


View Scopus Profile    View Oricd Profile

Featured Publications


Regulation of laboratory-developed tests and in-house in vitro diagnostic medical devices in the United States and the European Union—a comparative overview

– Review Article (Open Access)

Quality improvement report: Investigating barriers in HIV testing oncology patients to optimize HIV testing practice

– HIV Medicine

Tumor immune dynamics and long-term clinical outcome of stage IIIA NSCLC patients treated with neoadjuvant chemoimmunotherapy

– Nature Communications

Brief Report: Post Hoc Validation of Platinum Ineligibility in NSCLC From the Phase III IPSOS Study

– Journal of Thoracic Oncology

Transcriptome analysis of archived tumors by Visium, GeoMx DSP, and Chromium reveals patient heterogeneity

– Nature Communications
Solange Peters | Oncology | Research Excellence Award

You May Also Like